READ FULL ARTICLE >

The COVID-19 pandemic caused by the SARS-CoV-2 virus has left many unanswered questions for patients with neurological disorders and the providers caring for them. Elderly and immunocompromised patients are at increased risk for severe symptoms due to COVID-19, and the virus may increase symptoms of underlying neurological illness, particularly for those with significant bulbar and respiratory weakness or other neurologic disability. Emerging SARS-CoV-2 vaccines offer substantial protection from symptomatic infection, but both patients and providers may have concerns regarding theoretical risks of vaccination, including vaccine safety and efficacy in the context of immunotherapy and the potential for precipitating or exacerbating neurological symptoms. In this statement on behalf of the Quality Committee of the AAN we review the current literature, focusing on COVID-19 infection in adults with neurological disease, in order to elucidate risks and benefits of vaccination in these individuals. Based on existing evidence, neurologists should recommend COVID-19 vaccination to their patients. For those patients being treated with immunotherapies, attention should be paid to timing of vaccination with respect to treatment and the potential for an attenuated immune response.

READ FULL ARTICLE >

SOURCE: 2KUTV

SALT LAKE CITY (KUTV) -- Utah’s senior senator is throwing the weight of his office behind a push to get the CDC to recognize and help people injured by the COVID-19 vaccines, even if those injuries are rare.

Two weeks ago, Sen. Mike Lee (R-UT) announced his effort to help a Utah woman who’s suffering neurological trauma after receiving a COVID-19 vaccine.

“The best way to calm fears about COVID vaccines is to be open and forthcoming about possible side effects," Lee stated.

“It has come to our attention that several hundred individuals in the United States have experienced life-altering injuries after receiving COVID-19 vaccines," Lee stated in a letter to the director and acting commissioner of the Centers for Disease Control and Prevention.

READ FULL ARTICLE >

Source: COVID-19 Immunity Task Force

The Government of Canada, through its COVID-19 Immunity Task Force (CITF) and Vaccine Surveillance Reference Group (VSRG), is investing approximately $800,000 for a study that aims to further improve Canada’s identification and response to adverse events people may experience following COVID-19 vaccination across 10 provinces. This study is an extension of an existing vaccine safety program that provides important public health information about adverse events following immunization (AEFI) for all vaccines authorized for use in adults and children.

“While the benefits of the COVID-19 vaccination continue to outweigh the risks, when a patient develops an unexpected or serious adverse event that requires medical attention, it is important we determine the possible role of the vaccine and the safety of giving future vaccine doses to this specific person or to people with similar adverse events,” explains Dr. Karina Top, Principal Investigator (PI) of the project and lead investigator of the Canadian Immunization Research Network’s (CIRN) Special Immunization Clinic (SIC) Network, which is conducting the study. Dr. Top is also an Associate Professor in the Department of Pediatrics and Community Health and Epidemiology at Dalhousie University and an investigator at the Canadian Center for Vaccinology.

READ FULL ARTICLE >

Source: ABC

SARATOGA SPRINGS, Utah (ABC4) – A Utah woman and Utah senator are teaming up to get some answers after a group claims they’ve experienced life-altering injuries that they believe are from the COVID-19 vaccine.

While the symptoms haven’t been officially linked to the vaccine by the Centers for Disease Control and Prevention, some people are convinced that the two are related, including Brianne Dressen.

READ FULL ARTICLE >

SOURCE: Wiley Online Library

With interest, we read the article by Lu et al. about a systematic review of published neurological adverse reactions to SARS-CoV-2 vaccines.1 Included were 48 articles, and it was concluded that no severe neurological adverse reactions to any of the currently available SARS-CoV-2 vaccines have been reported.1 The review is appealing but raises the following comments and concerns.

We disagree with the conclusions that SARS-CoV-2 vaccines do not trigger neurological adverse reactions. Though rare, mild and severe neurological side effects have been occasionally reported.2 Search platforms and data bases to detect scientific reports about neurological adverse events may not be particularly helpful and do not provide many hits, but thorough assessments of various publications and their reference lists may help to find appropriate publications. Data from the mRNA vaccine clinical trials showed that 7 cases out of 37,000 vaccine recipients developed Bell's palsy.

READ FULL ARTICLE >

Source: Fox News

Mother Stephanie De Garay joins ‘Tucker Carlson Tonight’ to discuss how her 12-year-old daughter volunteered for the Pfizer vaccine trial and is now in a wheelchair.

See Video Interview >